Friday March 24, Florence

Friday March 24, Florence

00.01 - 23.59
WCO-IOF-ESCEO
08.00
Opening of the commercial exhibition
08.00 - 09.00
NON-SPONSORED SYMPOSIA
Meeting Room 1
Bone health: A reflection of the social mosaic
Chairperson: ‣ Gustavo Duque
‣ Medieval evidence: Reconstructing social status from British Medieval skeletons Justyna Miszkiewicz
‣ Contemporary evidence: Social gradient of osteoporosis Sharon L. Brennan‑Olsen
‣ Epigenetic evidence: Chronic stress, inflammatory response and osteoporosis risk José Riancho
‣ Moderated panel and audience questions All
Meeting Room 2
IOF-ASBMR Symposium: Fracture risk assessment to target treatment: Effectiveness and cost-utility
Chairpersons: ‣ Bo Abrahamsen, ‣ John A. Kanis
‣ Innovations in Approach to absolute risk assessment Cyrus Cooper
‣ Prospective RCTs to evaluate effectiveness of such strategies Michael R. McClung
‣ Economic Consequences of Treatment on basis of fracture risk assessment Eugene McCloskey
Meeting Room 3
Can exercise counter inflammation in the aged?
Chairperson: ‣ Ivan Bautmans
‣ Immunosenescence and impact of exercise on cellular markers Hung Cao Dinh
‣ Chronic low-grade inflammation and effects of exercise Keliane Liberman
‣ Anti-inflammatory effects of resistance training: dose-response relationship Louis Nuvagah Forti
Meeting Room 4
Diagnosis and Management of Fibrous dysplasia / McCune Albright syndrome: A global patient pathway
Chairperson: ‣ Kassim Javaid
‣ Introduction and Mission Statement of the International Consortium Kassim Javaid
‣ Pathophysiology of skeletal and extra-skeletal manifestations of FD/MAS Naveen Hamdy
‣ Consensus Clinical Care Pathway Kassim Javaid
‣ Therapeutic options in FD/MAS (including surgical, skeletal and endocrine; current and future) Roland D. Chapurlat
‣ Panel Discussion All
Meeting Room 6
Global differences in dietary calcium intake
Chairperson: ‣ Bess Dawson‑Hughes
‣ Introduction : including the role of calcium in bone growth and preservation Bess Dawson‑Hughes
‣ Presentation of the Calcium Map results Ethan Balk
‣ Presentation on the skeletal consequences of inadequate calcium intake Peter R. Ebeling
09.00 - 12.10
Auditorium A
SCIENTIFIC SESSION I
Chairpersons: ‣ John A. Kanis, ‣ Jean‑Yves Reginster
09.00
Auditorium A
Plenary Lecture 1
‣ Who and when to treat in osteoporosis? John A. Kanis
09.30
Auditorium A
Oral communications selected from abstracts
09.30
Auditorium A
OC1
‣ ABALOPARATIDE-SC DECREASES VERTEBRAL, NONVERTEBRAL, MAJOR OSTEOPOROTIC, AND WRIST FRACTURES IN A SUBSET OF POSTMENOPAUSAL WOMEN AT HIGH RISK OF FRACTURE BY FRAX SCORE
Presenting author: ‣ E. V. McCloskey
Authors: ‣ L. A. Fitzpatrick, ‣ M. Hu, ‣ J. A. Kanis
09.40
Auditorium A
OC2
‣ ABALOPARATIDE-SC SIGNIFICANTLY REDUCES VERTEBRAL AND NONVERTEBRAL FRACTURES AND INCREASES BONE MINERAL DENSITY REGARDLESS OF BASELINE RISK: RESULTS FROM THE ACTIVE PHASE 3 CLINICAL TRIAL
Presenting author: ‣ L. A. Fitzpatrick
Authors: ‣ G. Hattersley, ‣ P. D. Miller, ‣ M. Hu, ‣ L. A. Russo, ‣ B. J. R. Riis, ‣ G. C.  Williams, ‣ F. Cosman
09.50
Auditorium A
OC3
‣ FRACTURE RISK REDUCTION WITH ROMOSOZUMAB: RESULTS OF A PHASE 3 STUDY IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
Presenting author: ‣ F. Cosman
Authors: ‣ D. B. Crittenden, ‣ J. D. Adachi, ‣ N. Binkley, ‣ E. Czerwinski, ‣ S. Ferrari, ‣ L. C. Hofbauer, ‣ E. Lau, ‣ E. M. Lewiecki, ‣ A. Miyauchi, ‣ C. A. F. Zerbini, ‣ C. E. Milmont, ‣ L. Chen, ‣ J. Maddox, ‣ P. D.  Meisner, ‣ C. Libanati, ‣ A. Grauer
10.00
Auditorium A
OC4
‣ ROMOSOZUMAB RAPIDLY REDUCES CLINICAL VERTEBRAL FRACTURE INCIDENCE: RESULTS FROM THE FRAME STUDY
Presenting author: ‣ P. Geusens
Authors: ‣ M. Oates, ‣ A. Miyauchi, ‣ J. D. Adachi, ‣ M. Lazaretti‑Castro, ‣ P. R. Ebeling, ‣ C. A. Perez Nino, ‣ C. J. Milmont, ‣ A. Grauer, ‣ C. Libanati
10.10
Auditorium A
OC5
‣ EFFECT OF DENOSUMAB COMPARED WITH RISEDRONATE IN GLUCOCORTICOID-TREATED INDIVIDUALS: RESULTS FROM THE 12-MONTH PRIMARY ANALYSIS OF A RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED STUDY
Presenting author: ‣ O. D.  Messina
Authors: ‣ R. B. Wagman, ‣ P. Geusens, ‣ J. D. Adachi, ‣ O. D.  Messina, ‣ R. Emkey, ‣ R. D. Chapurlat, ‣ N. S. Daizadeh, ‣ N. Pannacciulli, ‣ W. Lems
10.20
Auditorium A
OC6
‣ DISCONTINUATION OF DENOSUMAB AND ASSOCIATED VERTEBRAL FRACTURE INCIDENCE: ANALYSIS FROM FREEDOM AND ITS EXTENSION
Presenting author: ‣ S. Ferrari
Authors: ‣ J. P. Brown, ‣ N. Gilchrist, ‣ J.‑E. Beck Jensen, ‣ N. Pannacciulli, ‣ C. Recknor, ‣ C. Roux, ‣ S. Smith, ‣ O. Törring, ‣ I. Valter, ‣ R. B. Wagman, ‣ A. Wang, ‣ S. Cummings
10.30
Auditorium A
Plenary Lecture 2
‣ What can we expect from bone forming agents in the management of osteoporosis? Serge Ferrari
11.00
Auditorium A
Presentation of the ESCEO-IOF-UCB Awards
‣ Cyrus Cooper, ‣ Pascale Richetta
11.10
Auditorium A
Oral communications selected from abstracts
11.10
Auditorium A
OC7
‣ A NEW SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS OF LONG-TERM TRIALS OF PHARMACOLOGICAL TREATMENTS IN KNEE OSTEOARTHRITIS
Presenting author: ‣ L. C. Rovati
11.20
Auditorium A
OC8
‣ PHARMACEUTICAL-GRADE CHONDROITIN SULFATE IS AS EFFECTIVE AS CELECOXIB AND SUPERIOR TO PLACEBO IN SYMPTOMATIC KNEE OSTEOARTHRITIS: THE CHONDROITIN VS CELECOXIB VS PLACEBO TRIAL (CONCEPT)
Presenting author: ‣ J.‑Y. Reginster
Authors: ‣ J. Dudler, ‣ T. Blicharski, ‣ K. Pavelka, ‣ A. Lanzarotti
11.30
Auditorium A
OC9
‣ DISCOVERY OF A SMALL MOLECULE WNT PATHWAY INHIBITOR (SM04690) AS A POTENTIAL DISEASE MODIFYING TREATMENT FOR KNEE OSTEOARTHRITIS
Presenting author: ‣ N. E. Lane
Authors: ‣ V. Deshmukh, ‣ C. Barroga, ‣ M.‑Y. Hu, ‣ S. KC, ‣ Y. Yazici
11.40
Auditorium A
OC10
‣ THE ASSOCIATION OF KNEE OSTEOARTHRITIS AND PREMATURE MORTALITY IN THE COMMUNITY: AN INTERNATIONAL INDIVIDUAL PATIENT LEVEL META-ANALYSIS IN SIX PROSPECTIVE COHORTS
Presenting author: ‣ K. M. Leyland
Authors: ‣ L. S.  Gates, ‣ M. T.  Sanchez‑Santos, ‣ D. Prieto‑Alhambra, ‣ A. Fudge, ‣ G. Collins, ‣ R. Cleveland, ‣ D. Felson, ‣ J. M. Jordan, ‣ L. F. Callahan, ‣ M. Nevitt, ‣ F. Saberi Hosnijeh, ‣ J. B. J. van Meurs, ‣ G. Jones, ‣ J. L. Newton, ‣ M. Batt, ‣ D. Altman, ‣ C. Cooper, ‣ N. K. Arden
11.50
Auditorium A
OC11
‣ OSTEOARTHRITIS INCREASES THE RISK OF CARDIOVASCULAR DISEASE: DATA FROM THE OSTEOARTHRITIS INITIATIVE
Presenting author: ‣ N. Veronese
Authors: ‣ T. Smith, ‣ J.‑Y. Reginster, ‣ S. Maggi
12.00
Auditorium A
OC12
‣ A RANDOMISED DOUBLE-BLIND PLACEBO-CONTROLLED CROSSOVER TRIAL OF ADALIMUMAB FOR EROSIVE HAND OSTEOARTHRITIS – THE HUMOR TRIAL
Presenting author: ‣ D. Aitken
Authors: ‣ L. Laslett, ‣ F. Pan, ‣ N. Bellamy, ‣ P. Bird, ‣ I. Haugen, ‣ G. Jones
14.00 - 15.00
Meeting Room 6
ESCEO-EUGMS HONORARY LECTURE
‣ IL-17 in bone, cartilage and muscle diseases : State of the art and practical consequences for the patient Pierre Miossec
14.00 - 15.00
WHO SYMPOSIUM
Meeting Room 3
Integrated Care for Older People (launch of the ICOPE Guidelines)
Chairpersons: ‣ Roger A. Fielding, ‣ John Beard
‣ Introduction John Beard
‣ Community care model for optimizing trajectories of intrinsic capacity Islene Araujo de Carvalho
‣ Screening for declines in intrinsic capacity in older people: a personalized approach to promote healthy ageing Matteo Cesari
‣ Role of nutrition and physical exercise in maintaining intrinsic capacity Olivier Bruyère
‣ Closing the evidence to practice gap: WHO ICOPE guideline recommendations Jotheeswaran Amuthavalli Thiyagarajan
‣ Discussion
14.00 - 15.00
MEET-THE-EXPERT SESSIONS
Meeting Room 2
Diabetes and bone
‣ Serge Ferrari
Meeting Room 4
Bone fragility during childhood, young adulthood and before the menopause
‣ Ego Seeman
Meeting Room 1
What can we expect from biomarkers in osteoarthritis?
‣ Gabriel Herrero‑Beaumont
14.00 - 15.00
Poster area
Poster Viewing Session I
14.00 - 15.10
Podium
Oral presentation of selected posters
Chairperson: ‣ Elaine M. Dennison
14.00
Podium
P564
‣ BONE MICROARCHITECTURE ANALYSIS BY HR-PQCT OF YOUNG ADULTS WITH KLINEFELTER SYNDROME REVEALED SEVERE BONE FRAGILITY
Presenting author: ‣ C. B. Confavreux
Authors: ‣ A. Piot, ‣ P. S. Szulc, ‣ J. Baccheta, ‣ S. Ailloud, ‣ H. Lejeune, ‣ R. D. Chapurlat, ‣ S. Boutroy, ‣ I. Plotton
14.07
Podium
P810
‣ FACTORS INFLUENCING END OF LIFE COST AND SURVIVAL IN ELDERLY OSTEOPOROTIC FRACTURE COHORTS
Presenting author: ‣ T. D. Tosteson
Authors: ‣ Q. Yang, ‣ A. N. Tosteson, ‣ J. Munson, ‣ Z. Li
14.14
Podium
P133
‣ PREPUBERTAL IMPACT OF PROTEIN INTAKE AND PHYSICAL ACTIVITY ON WEIGHT BEARING PEAK BONE MASS AND STRENGTH IN HEALTHY MALES
Presenting author: ‣ T. Chevalley
Authors: ‣ J.‑P. Bonjour, ‣ M.‑C. Audet, ‣ F. Merminod, ‣ B. van Rietbergen, ‣ R. Rizzoli, ‣ S. Ferrari
14.21
Podium
P667
‣ MUSCLE STRENGTH AND PHYSICAL PERFORMANCE FROM MIDLIFE AND BONE HEALTH IN EARLY OLD-AGE: THE MRC NATIONAL SURVEY OF HEALTH AND DEVELOPMENT
Presenting author: ‣ K. A. Ward
Authors: ‣ D. Kuh, ‣ S. Muthuri, ‣ A. Moore, ‣ C. Cooper, ‣ R. Cooper
14.28
Podium
P375
‣ RELATIONSHIPS BETWEEN MARKERS OF INFLAMMAGING AND BONE MICROARCHITECTURE: FINDINGS FROM THE HERTFORDSHIRE COHORT STUDY
Presenting author: ‣ N. R. Fuggle
Authors: ‣ L. D. Westbury, ‣ H. E. Syddall, ‣ N. A. Duggal, ‣ E. M. Dennison, ‣ J. Lord, ‣ C. Cooper
14.35
Podium
P841
‣ ANALYZING THE CORTICAL AND TRABECULAR BONE OF TENOFOVIR-TREATED HIV PATIENTS USING 3D-DXA.
Presenting author: ‣ R. Güerri‑Fernandez
Authors: ‣ L. Humbert, ‣ X. Nogués, ‣ N. Garcia‑Giralt, ‣ L. Mellibovsky, ‣ H. Knobel, ‣ A. Diez‑Perez
14.42
Podium
P756
‣ CLUSTER ANALYSIS OF BONE MICROARCHITECTURE FROM HIGH RESOLUTION PERIPHERAL QUANTITATIVE COMPUTED TOMOGRAPHY (HR-PQCT) AND FRACTURE IN THE GLOW STUDY
Presenting author: ‣ A. E. Litwic
Authors: ‣ L. D. Westbury, ‣ D. E. Robinson, ‣ K. A. Ward, ‣ C. Cooper, ‣ E. M. Dennison
14.49
Podium
P1040
‣ THE ELEVATED LEVELS OF BONE TURNOVER MARKERS IN YOUNG MEN ARE ASSOCIATED WITH BONE LOSS: A LONGITUDINAL STUDY IN HEALTHY YOUNG ADULTS
Presenting author: ‣ C. Verroken
Authors: ‣ S. Goemaere, ‣ H. Zmierczak, ‣ K. Toye, ‣ B. Lapauw, ‣ J.‑M. Kaufman
14.56
Podium
P676
‣ EFFECTS OF ABALOPARATIDE-SC ON BONE MINERAL DENSITY AND RISK OF FRACTURE IN POSTMENOPAUSAL WOMEN AGED 80 YEARS OR OLDER WITH OSTEOPOROSIS
Presenting author: ‣ M. R. McClung
Authors: ‣ N. C. Harvey, ‣ L. A. Fitzpatrick, ‣ P. D. Miller, ‣ G. Hattersley, ‣ Y. Wang, ‣ F. Cosman
15.03
Podium
P747
‣ COST-EFFECTIVENESS OF COMPLYING WITH TREATMENT GUIDELINES IN SWEDEN
Presenting author: ‣ E. Jonsson
Authors: ‣ A. Hansson‑Hedblom, ‣ O. Ljunggren, ‣ K. Åkesson, ‣ A. Spangeus, ‣ F. Borgström, ‣ J. A. Kanis
14.00 - 15.00
ESCEO SYMPOSIUM
Meeting Room 5
Identification and management of patients at imminent risk of osteoporotic fracture
Chairpersons: ‣ Bernard Cortet, ‣ Bo Abrahamsen
‣ Welcome and scope of the problem Cyrus Cooper
‣ How can we define a patient at imminent risk of fracture? Nicholas Harvey
‣ Efficacy of currently available treatments in patients at imminent risk of fracture Thierry Thomas
‣ Discussion : Leader: Salvatore Minisola
‣ Wrap-up and conclusion Cyrus Cooper
Panel: ‣ Bo Abrahamsen, ‣ Maria Luisa Brandi, ‣ Jorge Cannata Andia, ‣ Cyrus Cooper, ‣ Bernard Cortet, ‣ Hans Peter Dimai, ‣ Serge Ferrari, ‣ Peyman Hadji, ‣ Nicholas Harvey, ‣ John A. Kanis, ‣ Marius Kraenzlin, ‣ Andreas Kurth, ‣ Eugene McCloskey, ‣ Salvatore Minisola, ‣ Jean‑Yves Reginster, ‣ René Rizzoli, ‣ Thierry Thomas
15.00 - 16.45
Meeting Room 6
IOF COMMITTEE OF NATIONAL SOCIETIES SPECIAL PLENARY SESSION
Chairperson: ‣ Jean‑Yves Reginster
15.03
Meeting Room 6
OCs1
‣ BONE MINERAL DENSITY AT PATIENTS OF EARLY ONSET RHEUMATOID ARTHRITIS
Presenting author: ‣ B. Rexhepi
Authors: ‣ S. Rexhepi, ‣ M. Rexhepi, ‣ V. Sahatçiu‑Meka, ‣ M. Qorolli
15.11
Meeting Room 6
OCs2
‣ ASSOCIATION BETWEEN GENETIC FACTORS OF OSTEOPOROSIS AND FRAX® CALCULATED TEN-YEAR FRACTURE PROBABILITY
Presenting author: ‣ P. Marozik
Authors: ‣ E. Rudenka, ‣ K. Liaonchyk, ‣ A. Rudenka, ‣ O. Samakhavets
15.19
Meeting Room 6
OCs3
‣ IN-OFFICE PROTEOMIC PLATFORM FOR BONE MARKER MEASUREMENT
Presenting author: ‣ B. Larijani
Authors: ‣ P. Khashayar, ‣ G. Amoabediny, ‣ J. Vanfleteren
15.27
Meeting Room 6
OCs4
‣ BODY MASS INDEX, VITAMIN D DEFICIENCY AND PHYSICAL ACTIVITY IN OSTEOPOROSIS
Presenting author: ‣ R. Alimanovic‑Alagic
Authors: ‣ S. Sokolovic, ‣ M. Vrcic, ‣ A. Kapetanovic, ‣ E. Rabari, ‣ S. Hodzic
15.35
Meeting Room 6
OCs5
‣ COMPARATIVE STUDY OF FRAX® SCORE IN ECUADORIAN POPULATION
Presenting author: ‣ O. D.  Messina
Authors: ‣ G. Maldonado, ‣ C. Paredes, ‣ R. Guerrero, ‣ M. Mieles, ‣ C. Rios
15.43
Meeting Room 6
OCs6
‣ DEVELOPMENT AND VALIDATION OF ANTHROPOMETRIC PREDICTION MODEL FOR ESTIMATION OF MUSCLE MASS IN THE ELDERLY
Presenting author: ‣ B. Larijani
Authors: ‣ R. Heshmat, ‣ G. Shafiee, ‣ A. Keshtkar
15.51
Meeting Room 6
OCs7
‣ IMPORTANCE OF THE JOURNAL AND WEBSITE BONE HEALTH FOR PATIENTS WITH OSTEOPOROSIS AND OTHER MUSCULOSKELETAL DISEASES
Presenting author: ‣ M. Mukane
Authors: ‣ S. Upmale, ‣ M. Mukans, ‣ I. Rasa
15.59
Meeting Room 6
Presentation of the IOF Committee of National Societies Medal
‣ Jean‑Yves Reginster
16.07
Meeting Room 6
OCs8
‣ TBS, VFA AND HANDGRIP IN A GROUP OF POSTMENOPAUSAL WOMEN WITH VERTEBRAL FRACTURE
Presenting author: ‣ E. Czerwinski
Authors: ‣ J. Amarowicz, ‣ A. Kumorek, ‣ M. Warzecha
16.15
Meeting Room 6
OCs9
‣ DISCRIMINATIVE POWER OR ROMANIAN VERSION OF SARQOL QUESTIONNAIRE: PRELIMINARY RESULTS
Presenting author: ‣ A. I. Gasparik
Authors: ‣ G. Mihai, ‣ C. Sucaliuc, ‣ I. M. Pascanu
16.23
Meeting Room 6
OCs10
‣ IN PATIENT CARE FOR DIABETIC AND NON-DIABETIC PATIENTS WITH OSTEOPOROTIC HIP FRACTURES IN A FRACTURE LIAISON SERVICE AT AN ASIAN HOSPITAL: BRINGING THE BURDEN INTO THE SPOTLIGHT
Presenting author: ‣ M. Chandran
Authors: ‣ X. F. Huang, ‣ K. Choo, ‣ D. Tay, ‣ Y. Hao
16.31
Meeting Room 6
OCs11
‣ BALLOON KYPHOPLASTY COMPARED TO PERCUTANEOUS VERTEBROPLASTY: WHAT IS THE EVIDENCE?
Presenting author: ‣ P. R. Ebeling
Authors: ‣ A. J.  Rodriguez, ‣ H. A. Fink, ‣ L.  Mirigian, ‣ N. Guanabens, ‣ R. Eastell, ‣ K. Åkesson, ‣ D. C.  Bauer
15.00 - 17.00
Auditorium A
SCIENTIFIC SESSION II
Chairpersons: ‣ Cyrus Cooper, ‣ René Rizzoli
15.00
Auditorium A
Plenary Lecture 3
‣ Implication of bone biomechanics in daily practice Mary L. Bouxsein
15.30
Auditorium A
Presentation of the IOF President's Awards
‣ John A. Kanis
15.40
Auditorium A
Oral communications selected from abstracts
15.40
Auditorium A
OC13
‣ PREMENOPAUSAL WOMEN WITH EARLY BREAST CANCER TREATED BY OESTRADIOL SUPPRESSION HAVE SEVERELY DETERIORATED BONE MICROSTRUCTURE
Presenting author: ‣ S. K. Ramchand
Authors: ‣ E. Seeman, ‣ X.‑F. Wang, ‣ A. Ghasem‑Zadeh, ‣ P. A. Francis, ‣ E. J. Ponnusamy, ‣ M. S.  Bardin, ‣ M. Bui, ‣ J. D.  Lajac, ‣ M. Grossmann
15.50
Auditorium A
OC14
‣ WOMEN IDENTIFIED AT HIGH RISK BASED ON FRAX HIP FRACTURE PROBABILITY ARE RESPONSIVE TO APPROPRIATE OSTEOPOROSIS MANAGEMENT: ANALYSIS FROM THE SCOOP STUDY OF POPULATION SCREENING
Presenting author: ‣ E. V. McCloskey
Authors: ‣ N. C. Harvey, ‣ H. Johansson, ‣ L. Shepstone, ‣ E. Lenaghan, ‣ C. Cooper, ‣ J. A. Kanis
16.00
Auditorium A
OC15
‣ CAN INDIVIDUALISED RISK FEEDBACK PRODUCE LONG-TERM HEALTH BENEFITS? A 10-YR FOLLOW-UP OF A 2-YR RANDOMISED CONTROLLED TRIAL OF FEEDBACK OF FRACTURE RISK
Presenting author: ‣ F. Wu
Authors: ‣ K. Wills, ‣ L. Laslett, ‣ M. Riley, ‣ B. Oldenburg, ‣ G. Jones, ‣ T. Winzenberg
16.10
Auditorium A
OC16
‣ MOBILITY RELATED RISK FACTORS PREDICT INCIDENT FRACTURES INDEPENDENTLY OF FRAX: THE OSTEOPOROTIC FRACTURES IN MEN (MROS) STUDY
Presenting author: ‣ N. C. Harvey
Authors: ‣ A. Odén, ‣ E. Orwoll, ‣ J. Lapidus, ‣ T. Kwok, ‣ M. Karlsson, ‣ B. E. Rosengren, ‣ O. Ljunggren, ‣ C. Cooper, ‣ J. A. Kanis, ‣ C. Ohlsson, ‣ D. Mellström, ‣ H. Johansson, ‣ E. V. McCloskey
16.20
Auditorium A
OC17
‣ IMMINENT RISK OF HIP FRACTURE AFTER RECENT (SENTINEL) FRACTURE – COMPARISON OF SENTINEL FRACTURE SITES (REYKJAVIK STUDY)
Presenting author: ‣ H. Johansson
Authors: ‣ K. Siggeirsdottir, ‣ N. C. Harvey, ‣ A. Odén, ‣ V. Gudnason, ‣ E. V. McCloskey, ‣ G. Sigurdsson, ‣ J. A. Kanis
16.30
Auditorium A
Plenary Lecture 4
‣ Emerging treatments for the management of osteoarthritis Tim McAlindon